The OXItek TBARS Kit is designed to provide a standardized, reproducible assay with consistent results. Each lot of reagents is quality controlled as a kit, which includes an MDA standard. It is recommended that additional in-house controls are included in each test run.

The OXItek TBARS Assay Kit is for Research Purposes Only.

which can be measured by fluorometry or spectrophotometry. Although this reaction has a much higher sensitivity when measured via fluorometry, protocols for both methods are provided in the Test Procedure section of this insert.

Biological specimens contain a mixture of thiobarbituric acid reactive substances (TBARS), including lipid hydroperoxides and aldehydes, which increase as a result of oxidative stress. TBARS return to normal levels over time, depending upon the presence of anti-oxidants. In practice, TBARS are expressed in terms of malondialdehyde (MDA) equivalents ⁽¹¹⁾ . In this assay, an MDA standard is used to construct a standard curve against which unknown samples can be plotted.

The OXItek TBARS Assay Kit provides all the necessary reagents to perform 160 tests and is designed for researchers studying oxidative stress and anti-oxidant activity. It is recommended that in-house controls be run with each sample test.

Limitation to Procedure:
1. Hemolyzed, icteric or lipemic plasma samples are not suitable for use in TBARS analysis.
2. Non-lipid TBARS may be present in the sample. It is recommended that a sample with elevated TBARS levels be tested by a more specific test for lipid peroxidation such as HPLC.
3. Normal tissues contain very low levels of free malondialdehyde

• Thiobarbituric Acid (4 vials/kit): Contains 0.53 grams thiobarbituric acid

• TBA Diluent 1 (4 x 50 ml/kit) : Contains acetic acid

• TBA Diluent 2 (4 x 50 ml/kit): Contains sodium hydroxide

• SDS Solution (30 ml/kit): Contains sodium doedecyl sulfate

• MDA Standard (10 ml/kit): Contains100nmol/ml Malondialdehyde Bis (dimethyl acetal)

• MDA Diluent (100 µl/kit):

Marbles

Store all kit reagents at 2-8 ° C. The components should be used before the expiration date indicated on the outside of the box.

Materials Required but not Supplied:

• 12 x 75 mm glass test tubes and metal racks
• Disposable gloves
• Adjustable pipettes
• Graduated cylinders and assorted beakers
• Stir plate
• Heat block, incubator or water bath set at 95 ° C
• Fluorometer or Spectrophotometer

• To avoid cross contamination, use separate pipette tips for each specimen.

• TBA Diluent 1 contains acetic acid. Handle and dispose of according to applicable legal and safety guidelines.

• TBA Diluent 2 contains sodium hydroxide. Handle and dispose of according to applicable legal and safety guidelines.

• If reusing glass tubes, be certain to rinse thoroughly in deionized water.

TBA/Buffer Reagent:

Use 1 bottle of TBARS Diluent 1 (50 ml), 1 bottle of TBARS Diluent 2 (50 ml) and 1 vial of Thiobarbituric Acid (TBA). One hundred ml is sufficient for approximately 40 tubes.

Dilute MDA Standard 1:10 by mixing 1.8 ml of MDA Diluent and 0.2 ml of MDA Standard. Mix thoroughly. Prepare a series of 5 standards in MDA Diluent. The dilution scheme for these standards is given below in Table 1.

Use MDA Standard undiluted for 100 nmol/ml standard. Prepare a series of 5 standards in MDA Standard Diluent. The dilution scheme for these standards is given below in Table 2.

Table 2: Preparation of MDA Standard For Spectrophotometer

Step 1: Collect EDTA plasma (lavender top Vacutainer^®). For preparation of other sample types, see sample preparation section of this insert.

Step 2:  Label each disposable glass test tube with the standard number or sample identification.

Step 3: Add 100 µl sample or standard to properly labeled tube.

Step 4: Add 100 µl SDS Solution to each tube and swirl to mix.

Step 10: Fluorescent Analysis: read supernatants with excitation set at 530 nm and emission at 550 nm. It is recommended sensitivity be set at high with a slit width of 5 nm. Spectrophotometer Analysis: Read absorbance of supernatants at 532 nm.

Platelets:

Collect 5 ml specimen of heparinized venous blood (green top Vacutainer^®) from patients who have fasted overnight. Remove stopper and let RBCs sediment by gravity. Pipet off platelet-rich plasma (PRP) into clean, plastic centrifuge tube after 1 ml has formed and continue until separation is complete. Centrifuge PRP at 1400 rpm for 5 min, collect supernatant and centrifuge the supernatant at 5000 rpm for 15 min to sediment platelets.

Collect blood in EDTA (lavender top Vacutainer^®). Allow RBCs to sediment; collect upper "Buffy Coat". Wash leukocytes contained in the Buffy Coat once in an isotonic solution such as saline or Dulbecco’s PBS. Resuspend leukocytes in isotonic solution for testing⁽¹⁵⁾.

Wash RBC pellet from leukocyte separation with 20 ml of TRIS Buffer, pH 7.4 (6.05 g TRIS, 6.42 g NaCl, 420 ml 0.1M HCl, 580 ml deionized water), centrifuge at 3500 rpm for 10 minutes, discard supernatant and repeat twice. Add an equal volume of TRIS Buffer to final pellet and incubate a minimum of 4 hours at 4 ºC. Lysis of erythrocytes is performed on ice with pre-cooled conditions. Add 15 ml lysing solution (301 mg MgSO₄, 372 mg KCl in 500 ml of sterile water) to 0.5 ml of the cell suspension. Immediately add 1 ml of resealing solution (53.7 g KCl, 10.5 g NaCl in 400 ml of deionized water). Keep the suspension on ice for 5 mn and then at 37 ºC for 30 min. Pellet the ghosts by centrifuging for 10 min at 3500 rpm⁽¹²⁾ .

Plasma: Collect fasting heparinized whole blood. Centrifuge at 3500 rpm for 10 minutes at 5-10ºC, carefully remove plasma and place on ice for immediate analysis or freeze several aliquots at -70 ºC for later analysis. Samples can be safely stored for 1-2 months. Process as described below for serum⁽³⁾.

Serum: Collect fasting whole blood in a red top vacutainer^®.. Incubate at room temperature for at least 30 minutes for clots to form. Centrifuge at 3500 rpm for 10 minutes. Carefully remove serum and place on ice for immediate analysis or freeze aliquots at -70 ºC for later analysis. Add 1.5 ml of isotonic saline to 1.5 ml of plasma/serum. Prepare a sodium heparin solution in water containing 40,000 USP units per ml. Prepare a solution of 1.06M manganese chloride in water. A working reagent is prepared with 300 µl sodium heparin solution to 5 ml manganese chloride solution. Scale up as necessary. Add 300 µl of working reagent to the diluted serum/plasma. Vortex and allow the LDL/VLDL to precipitate for 15 min at room temperature. Centrifuge the serum/plasma at 8000 rpm for 15 min. Decant the serum/plasma supernatant and resuspend the pellet in 1.5 ml normal saline or PBS^(3,13) . If required, sonicate each sample 5 sec at low setting over ice. Use these samples to start the TBARS assay, substituting water for SDS in the reaction mixture.

Note: When analyzing samples that may be non-fasting, triglycerides measuring above 300-350 mg/dL will yield a turbid supernatant and cannot be measured.

Freeze tissue in liquid nitrogen and immediately crush in a pre-chilled mortar and pestle. Resuspend tissue at 50 mg/ml in normal saline or PBS. Disrupt in a Potter-Elvejhem glass homogenizer. If necessary, sonicate for 15 sec at
40V setting over ice and use uncentrifuged whole homogenate for analysis. Alternatively, homogenize in isotonic media appropriate for sub-cellular fractionation to study TBARS in plasma membranes, nuclear membranes or

organelles. Spun supernates may be used for enzyme analyses. Recommend normalizing TBARS values to another constituent such as protein.

Cell Cultures:

Suspend 20 million cells in 1 ml of cell culture medium or buffer of choice such as PBS. Sonicate for 5 second intervals at 40 V setting over ice. Use whole homogenates in the assay, being sure to use culture fluid as a sample blank.

The TBARS assay may be used for testing anti-oxidants and drugs ⁽¹³⁾. Oxidize 2 100 µl aliquots of a sample, such as serum or plasma, with 5mM ferric chloride. Add the anti-oxidant compound to be tested to one. Incubate plasma alone plus the 2 test samples at 37^ºC for 30 min and compare to distilled water control. Calculate percentage of inhibition⁽¹⁴⁾ . Drugs may be added directly to plasma samples and compared to plasma alone in the TBARS assay

Typical Standard Curve (Fluorometer):
This is an example of a typical standard curve and is not to be used for interpretation of results. Variation may occur in individual laboratories due to pipetting, laboratory and incubator temperatures, etc.
 

Table 3: Sample Standard Curve

Typical Standard Curve (Spectrophotometer):
This is an example of a typical standard curve and is not to be used for interpretation of results. Variation may occur in individual laboratories due to pipetting, laboratory and incubator temperatures, etc.

Table 4: Sample Standard Curve

1. Yagi, K. Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Free Radical and Antioxidant    Protocols, 108: 101-106;1998
2. Armstrong, D. and Browne, R. The analysis of free radicals, lipid peroxidases, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Free Radicals in Diagnostic Medicine, 366:43-58;1994
3. Lef’evre G., et.al. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Annals de Biologie Clinique (Paris) May-June; 56(3):305-19; 1998
4. Janero, D. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biology & Medicine, 9:515-540; 1998
5. Callaway, J.K. et. al. A reliable procedure for comparison of antioxidents in rat brain homogenates. Journal of Pharmacology Toxicology Methods, April; 39(3):155-62; 1998
6. Jentzsh, AM., et. al. Improved analysis of malondialdehyde in human body fluids. Free Radio Biol Med., 20(2):251-6; 1996
7. Jo, C. et. al. Fluorometric analysis of 2-thiobarbituric acid reactive substances in turkey. Pout. Sci., March; 77(3):475-80; 1998
8. Villa-Caballero, L. et. al. Oxidative Stress. Should it be measured in the diabetic patient? Gac Med Mex, May-June; 136(3):249-56; 2000
9. Hunnisett A. et. al. Lipoperoxides as an index of free radical activity in bone marrow transplant recipients. Preliminary Observations. Biol Trace Elem Res, Jan-March; 47(1-3):125-32; 1995
10. Armstrong, D. and Browne, R. The analysis of free radicals, lipid peroxidases, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Free Radicals in Diagnostic Medicine, 366:46; 1994
11. Kwon,T. and Watts,B. Malonaldehyde in aqueous solution and its role as a measure of lipid oxidation in foods. Journal of Food Science, 29:294-302; 1964
12. Braun,D. and Fromherz,P. Fluorescence interference-contrast microscopy of cell adhesion on oxidized silicon. Applied Physics A, 1997
13. Gidez,L. et al. Separation and quantitation of subclasses of human plasma high density lipoproteins by simple precipitation procedure. Journal of Lipid Research, 23:1206-1223; 1982
14. Armstrong,D. et al. In vitro screening for antioxidant activity.Free Radical and Antioxidant Protocols, 108:315-324; 1998
15. Boyum, A. Separation of leukocytes from blood and bone marrow. Scandinavian Journal of Clinical Investigation 21, Supplement 97; 1966.

PREPARE REAGENTS

PIPET SPECIMENS AND CONTROLS

ADD SDS SOLUTION

ADD TBA/BUFFER REAGENT

INCUBATE 60 MIN AT 95º ±1º C

COOL TO ROOM TEMPERATURE

CENTRIFUGE SPECIMEN

READ RESULTS

* The OXI-TEK TBARS Assay Kit is for Research Purposes Only.